Clinical and Applied Thrombosis/Hemostasis
短名 | Clin Appl Thromb Hemost |
Journal Impact | 2.49 |
国际分区 | PERIPHERAL VASCULAR DISEASE(Q2) |
期刊索引 | SCI Q3中科院 4 区 |
ISSN | 1076-0296, 1938-2723 |
h-index | 63 |
国内分区 | 医学(4区)医学血液学(4区)医学外周血管病(4区) |
CATH 是一份经过同行评审的双月刊,旨在解决与管理出血和凝血障碍有关的实际临床和实验室问题,尤其是与血栓形成、止血和血管疾病相关的问题。 CATH 涵盖血栓出血性疾病的临床试验、病因学、病理生理学、诊断和治疗研究。
期刊主页投稿网址涉及主题 | 医学内科学生物外科心理学精神科化学生物化学免疫学病理遗传学心脏病学血栓形成血小板胃肠病学数学内分泌学物理统计 |
出版信息 | 出版商: SAGE Publications Inc.,出版周期: Quarterly,期刊类型: journal |
基本数据 | 创刊年份: 1995,原创研究文献占比: 86.39%,自引率:4.30%, Gold OA占比: 88.76% |
平均审稿周期 | 网友分享经验:平均2月 |
平均录用比例 | 网友分享经验:约50% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Anti-inflammatory Effect of Batroxobin Combined With Anticoagulation in Patients With Cerebral Venous Thrombosis
2024-7-21
Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy
2024-7-21
Prognosis and Factors 4 to 10 Years After Deep Vein Thrombosis: A Long-Term Follow-up Cohort Study
2024-1-1
Peripheral Blood Lymphocyte Subsets in Factor VIII Inhibitor-Positive Patients with Severe Hemophilia A: A Case-Control Study
2024-1-1
Coagulation Testing in Real-World Setting: Insights From a Comprehensive Survey
2024-1-1
A Novel Nomogram for Predicting Warfarin-Related Bleeding: A Retrospective Cohort Study
2024-1-1
Anti-Xa Monitoring of Apixaban (ZyQuis) in Venous Thrombo-Embolism and Atrial Fibrillation
2024-1-1
Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma
2024-1-1
The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension
2024-1-1
Development of a Risk Assessment Tool for Venous Thromboembolism among Hospitalized Patients in the ICU
2024-1-1
Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National Survey
2024-1-1
Efficacy and Safety of Long-Term Dual Antiplatelet Therapy: A Systematic Review and Meta-Analysis
2024-1-1
Immature Platelet Fraction and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation
2024-1-1
Diagnostic and Prognostic Value of C1q in Sepsis-Induced Coagulopathy
2024-1-1
Interpretable Machine Learning Models Using Peripheral Immune Cells to Predict 90-Day Readmission or Mortality in Acute Heart Failure Patients
2024-1-1
Knowledge, Adherence, and Satisfaction With Warfarin Therapy and Associated Factors Among Outpatients at University Teaching Hospital in Ethiopia
2024-1-1
Development and Validation of a Predictive Model for Intracranial Haemorrhage in Patients on Direct Oral Anticoagulants
2024-1-1
Assessing Venous Thrombotic Risks in Extracorporeal Membrane Oxygenation-Supported Patients: A Systematic Review and Meta-Analysis
2024-1-1
Role of Angiopoietin/Tie2 System in Sepsis: A Potential Therapeutic Target
2024-1-1
Venous Thromboembolism Risk and Adherence to Pharmacological Thromboprophylaxis in Hospitalized Patients in Uruguay: First Nationwide Study
2024-1-1
Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program
2024-1-1
The Role of HATCH Score in the Prediction of Ischemic Cerebrovascular Events in Patients with Heart Failure and Atrial Fibrillation
2024-1-1
A Call to Leadership: New VTE Treatment and Prevention Guidelines
2024-1-1
Evaluating of Existing VTE Risk Scales in Glioma Patients
2024-1-1
Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease
2024-1-1
Predictive Role of Pre-Thrombolytic Neutrophil-Platelet Ratio on Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke
2024-1-1
Factor Xa Inhibitors Versus Vitamin K Antagonists in Atrial Fibrillation Patients with End-Stage Kidney Disease on Dialysis: A Meta-Analysis
2024-1-1
Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure
2024-1-1
Prognosis in Patients with ST-Segment Elevation Myocardial Infarction Reperfused by PHDP: 1-Year MACEs Follow-Up
2024-1-1
Triglyceride-glucose Index as a Valuable Marker to Predict Severity of Coronary Artery Disease: A Retrospective Cohort Study
2024-1-1
Thanks to Reviewers
2024-1-1
Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC
2024-1-1
Nomogram for Risk of Secondary Venous Thromboembolism in Stroke Patients: A Study Based on the MIMIC-IV Database
2024-1-1
Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events
2024-1-1
Validation of the RIETE, Kuijer, and HAS-BLED Models to Assess 3-Month Bleeding Risk in Anticoagulated Patients Diagnosed with Venous Thromboembolic Disease
2024-1-1
The Predictive Value of the MELD Scores for In-Hospital Adverse Events in Normotensive Patients with Acute Pulmonary Embolism
2024-1-1
Thrombosis in Critically Ill Influenza Patients: Incidence and Risk Factors
2024-1-1
Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke
2024-1-1
Evaluation of Hemogram Parameters in the Diagnosis of Pulmonary Embolism: Immature Granulocytes and Other New Tips
2024-1-1
The Relationship of Coronary Thrombus Burden and Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Score in Patients With ST-Segment Elevation Myocardial Infarction
2024-1-1
Challenges to Laboratory Monitoring of Direct Oral Anticoagulants
2024-1-1
Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy
2024-1-1
Reference Value Fibrin Monomer in Healthy Children: A Cross-Sectional Study
2024-1-1
Risk Scores in Venous Thromboembolism Guidelines of ESC, ACCP, and ASH: An Updated Review
2024-1-1
Cardiac Arrest-Associated Coagulopathy Could Predict 30-day Mortality: A Retrospective Study from Medical Information Mart for Intensive Care IV Database
2024-1-1
Determination of vWF, ADAMTS-13 and Thrombospondin-1 in Venous Thromboembolism and Relating Them to the Presence of Factor V Leiden Mutation
2024-1-1
Biomarkers Profile in Provoked <i>Versus</i> Unprovoked Deep Venous Thrombosis
2024-1-1
Age is a Risk Factor for Poor Knowledge About Venous Thromboembolism Treatment
2024-1-1
Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database Study
2024-1-1
Incidence and Impact on Quality of Life of Heavy Menstrual Bleeding in Women on Oral Anticoagulant Therapy
2024-1-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远